{"organizations": [], "uuid": "94a18d7fa6ab55a37cfee45263fec72d55e2dcf5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180510.html", "section_title": "Archive News &amp; Video for Thursday, 10 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zomedica-signs-agreement-with-sera/brief-zomedica-signs-agreement-with-seraph-biosciences-for-innovative-veterinary-point-of-care-diagnostic-idUSFWN1SH0QD", "country": "US", "domain_rank": 408, "title": "BRIEF-Zomedica Signs Agreement With Seraph Biosciences For Innovative Veterinary Point-Of-Care Diagnostic", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.964, "site_type": "news", "published": "2018-05-10T18:58:00.000+03:00", "replies_count": 0, "uuid": "94a18d7fa6ab55a37cfee45263fec72d55e2dcf5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zomedica-signs-agreement-with-sera/brief-zomedica-signs-agreement-with-seraph-biosciences-for-innovative-veterinary-point-of-care-diagnostic-idUSFWN1SH0QD", "ord_in_thread": 0, "title": "BRIEF-Zomedica Signs Agreement With Seraph Biosciences For Innovative Veterinary Point-Of-Care Diagnostic", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "zomedica pharmaceuticals corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 10 (Reuters) - Zomedica Pharmaceuticals Corp:\n* ZOMEDICA SIGNS AGREEMENT WITH SERAPH BIOSCIENCES FOR INNOVATIVE VETERINARY POINT-OF-CARE DIAGNOSTIC\n* ZOMEDICA PHARMACEUTICALS - ENTERED INTO A DEVELOPMENT, COMMERCIALIZATION, EXCLUSIVE DISTRIBUTION DEAL WITH SERAPH BIOSCIENCES\n* ZOMEDICA PHARMACEUTICALS CORP - DEAL WITH SERAPH COVERS DEVELOPMENT & VALIDATION OF ZM-020 Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-10T18:58:00.000+03:00", "crawled": "2018-05-11T12:32:44.044+03:00", "highlightTitle": ""}